IgE Allergy Blood Tests Market Size & Share, by Product Type {Assays & Kits, ELISA Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA)}; Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms); End-User (Diagnostic Laboratories, Specialty Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5551
  • Published Date: Jan 22, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

IgE Allergy Blood Tests Market size is estimated to cross USD 53 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of IgE allergy blood tests was about USD 31 Billion. The major factor influencing the market expansion is the rising prevalence of asthma. With a projected 262.41 million prevalent cases (95% UI 224.05 to 309.45) worldwide, the burden of asthma has continued to climb. Hence, the demand for IgE allergy blood tests is growing. Asthma sufferers undergoing allergy testing typically have their IgE levels checked for airborne allergens that are known to frequently impact their symptoms.

Additionally, there has been growing awareness regarding the prevalence of allergies all across the globe by the government. They are launching various campaigns where they are offering free testing for allergies. This is why, the IgE allergy blood tests market is observing the growth in its revenue. 

IgE Allergy Blood Tests Market
Get more information on this report: Request Free Sample PDF

IgE Allergy Blood Tests Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

~ USD 31 Billion

Forecast Year Market Size (2036)

~ USD 53 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

IgE Allergy Blood Tests Market: Growth Drivers and Challenges


Growth Drivers

  • Surge in Pollution Level - According to WHO data, practically all people on the globe (99%) inhale air that is polluted to high levels and exceeds WHO guideline limits; low- and middle-income countries are particularly exposed. Furthermore, 2.4 billion people use polluting open fireplaces or basic stoves powered by coal, kerosene, biomass (wood, animal dung, and agricultural waste), and various other household pollutants, subjecting them to dangerously high levels of air pollution at home. This has further increased the prevalence of allergies. There is a stronger correlation between air pollution and a higher incidence of allergies. A higher concentration of proteins classified as allergenic can be found in pollen in areas with high pollution levels. By getting into physical touch with the pollen particles, DEPs can disrupt the latter. This may result in the release of paucimicronic particles, which then travel by air and have an easier time entering human airways hence further causing allergies.
  • Growing Utilization of mHealth  - Through online marketplaces including Google Play for Android devices and Apple's "App Store" for iOS devices (iPhone, iPad), a vast array of programmes are offered to the general public. Apps have grown more and more popular among patients and healthcare professionals as they are simple to utilize. It has been demonstrated that mHealth apps improve patient-centered outcomes, and physicians frequently recommend apps to their patients. Apps benefit patients of various ages and levels of education due to their diverse feature sets, which include action plans, games, educational content, diaries, and reminders. mHealth apps may remind users to take their prescriptions by sending automated scheduled reminders every day or several times a day. Research has demonstrated that SMS medication reminders for particular chronic illnesses, including asthma, have greatly increased treatment adherence rates across all age groups. Hence, with the growing adoption of mHealth the IgE allergy blood tests market is growing.
  • Rising Prevalence of Food Allergies  - To identify and treat food allergies more effectively, allergen-specific IgE testing is occasionally utilized. Some individuals who are prone to food allergies develop antibodies against specific foods since their immune systems erroneously see them as foreign invaders. For example, people opts for gluten-free food, as they are gluten intolerant. IgE antibodies are the sort of antibodies that are generated. These are distinct from IgG antibodies, which are critical in the defense against viruses and bacteria. For determining if a person is allergic to a food, allergen-specific IgE testing can identify elevated levels of food-specific IgE.


  • High Cost Associated with Testing Instruments - Market participants frequently update an array of allergy diagnostic tools, including luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. The aforementioned instruments are more expensive since they have more features and functionalities (the cost of each instrument varies depending on its accuracy, versatility, and TAT). In addition, extra expenses for operating this technology include overhead (such as electricity, space, and administration), laboratory supervision, maintenance, and insurance. Large hospitals and testing facilities hold a larger IgE allergy blood tests market share because they can afford high-volume systems because of their robust capital budgets. However, because of financial limitations, the majority of small labs, doctor's offices, and independent practitioners are typically unable to purchase huge or extremely large systems.
  • Lack of Awareness Among the General Public 
  • Lack of Professionals to Handle the Instruments 

IgE Allergy Blood Tests Segmentation

End-User (Diagnostic Laboratories, Specialty Clinics, Hospitals, Research & Academic Centers)

The diagnostics laboratories segment in the IgE allergy blood tests market is estimated to gather the highest share of over 40% during the forecast period. Diagnostic lab services are essential to the healthcare industry since they are vital to the diagnosis and management of diseases. Furthermore, a clear role for the diagnostics laboratory exists in the diagnosis and treatment of allergy sufferers. Furthermore, diagnostics laboratories have a huge availability of funds and the latest technology as compared to hospitals. In the past, when diagnostic testing services were less developed, medical professionals relied on a patient's symptoms to determine what was allegedly wrong and recommend medication. Frequently, the patient's symptoms were ambiguous, and the wrong problem was being addressed. However, this is no longer an issue as a result of developments in technology and medicine. Diagnostic centers today offer several examinations for allergies. As a result, the preference for diagnostics laboratories is growing.

Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms, Medicine Allergies, Latex/Metal Allergies)

The food allergies segment is expected to hold 30% share of the global IgE allergy blood tests market during the forecast period. In addition to being obtained through food, vitamin D is produced by the human body when exposed to sunshine. Due in large part to the immune system's regulation by vitamin D, the prevalence of food allergies has risen as vitamin D levels have decreased between nations. According to study data, 50% of the global population suffers from vitamin D insufficiency, while approximately 1 billion people worldwide suffer from vitamin D deficiency.

Our in-depth analysis of the global IgE allergy blood tests market includes the following segments:

     Product Type

  • Assays & Kits
  • ELISA Testing Kits
  • Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
  • Chemiluminescent Immunoassays (CLIA)
  • Reagents, Consumables
  • Analyzers


  • Aero Allergies, Indoor Allergies
  • Outdoor Allergies
  • Food Allergies
  • Venoms
  • Medicine Allergies
  • Latex/Metal Allergies


  • Diagnostic Laboratories
  • Specialty Clinics
  • Hospitals
  • Research & Academic Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

IgE Allergy Blood Tests Industry - Regional Synopsis

North American Market Forecast

The North America IgE allergy blood tests market is poised to hold 30% of the revenue share in the coming years. The major element to influence the market expansion is the growing adoption of health insurance. In 2022, more individuals had insurance than in 2021. Moreover, 2022 saw a rise in the proportion of the population with health insurance from 91.7 percent in 2021 to 92.1 percent in 2022 in the US, or 304.0 million individuals, who were insured at some point in the year. Furthermore, for public as well as private sector employees, purchasing a health insurance policy has been made mandatory in various organizations in this region. Key medical benefits are given by health insurance, which employees can use when employed by a business. Health insurance coverage is very helpful in covering treatment costs in the event of an emergency or other medical problem. Additionally, there has been a rise in the development of various instruments by key players for more advanced testing which is also estimated to boost the IgE allergy blood tests market expansion in this region.

APAC Market Analysis

The IgE allergy blood tests market in Asia Pacific is also estimated to have notable growth during the coming years. The market in this region is expanding owing to the increased attention being paid to personalized medication and the expanding knowledge of allergic disorders. The IgE allergy blood tests market growth potential in this region is further enhanced by the incorporation of these tests into standard healthcare regimens.

Research Nester
IgE Allergy Blood Tests Market  size
Get more information on this report: Request Free Sample PDF

Companies Dominating the IgE Allergy Blood Tests Market

    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis  
    • Eurofins Viracor
    • Neogen Corporation
    • Omega Diagnostics PLC
    • Abionic SA
    • Amerimmune LLC
    • AXO Science
    • Biovator AB
    • China Medical Technologies Inc
    • Cytognos, SL


In The News

  • The U.S. Food & Drug Administration (FDA) has cleared Thermo Fisher Scientific's ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies. These cutting-edge blood tests, which are also anticipated to be made available countrywide, can serve as a diagnostic tool for physicians and other healthcare professionals by assisting in the identification of wheat and sesame allergies in patients who may experience a severe allergic reaction.
  • Leading provider of immunology and infectious disease testing, Eurofins Viracor, officially opened its new, large laboratory in Lenexa, Kansas, today. With 215 current employees and 235 newly created roles, the 110,000 square foot, state-of-the-art facility will employ 450 people and provide additional capacity to support development in biopharma and transplant diagnostic testing services.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5551
  • Published Date: Jan 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are a surge in pollution levels, growing utilization of mHealth, and rising prevalence of food allergies.

The market size of IgE allergy blood tests is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Thermo Fisher Scientific, Inc., Eurofins Viracor, Neogen Corporation, Omega Diagnostics PLC and others.

The diagnostics laboratories segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
IgE Allergy Blood Tests Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying